pemetrexed krka 100 mg/1 bočica prašak za koncentrat za otopinu za infuziju
krka farma d.o.o. sarajevo - pemetreksed - prašak za koncentrat za otopinu za infuziju - 100 mg/1 bočica - jedna bočica sadrži: 100 mg pemetrekseda (u obliku pemetreksed dinatrij hemipentahidrata)
pemetreksed sandoz 25 mg/ml koncentrat za otopinu za infuziju
sandoz d.o.o., maksimirska 120, zagreb, hrvatska - pemetrekseddinatrij hemipentahidrat - koncentrat za otopinu za infuziju - 25 mg/ml - urbroj: svaki ml koncentrata za otopinu za infuziju sadrži 25 mg pemetrekseda
pemetrexed ever pharma 25 mg/ml koncentrat za otopinu za infuziju
ever valinject gmbh, oberburgau 3, unterach am attersee, austrija - pemetrekseddinatrij hemipentahidrat - koncentrat za otopinu za infuziju - 25 mg/ml - urbroj: jedan ml koncentrata sadrži 25 mg pemetrekseda (u obliku pemetrekseddinatrija)
pemetreksed pliva 500 mg/1 bočica prašak za koncentrat za otopinu za infuziju
pliva d.o.o.sarajevo - pemetreksed - prašak za koncentrat za otopinu za infuziju - 500 mg/1 bočica - 1 bočica sa praškom za koncentrat za otopinu za infuziju sadrži: 500 mg pemetrekseda (u obliku pemetrekseddinatrija)
pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastična sredstva - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.
eslikarbazepinacetat accord 200 mg tablete
accord healthcare polska sp. z o.o., ul. tasmowa 7, mazowieckie, varšava, poljska - eslicarbazepinum - tableta - 200 mg - urbroj: jedna tableta sadrži 200 mg eslikarbazepinacetata
eslikarbazepinacetat accord 800 mg tablete
accord healthcare polska sp. z o.o., ul. tasmowa 7, mazowieckie, varšava, poljska - eslicarbazepinum - tableta - 800 mg - urbroj: jedna tableta sadrži 800 mg eslikarbazepinacetata
glukoza sa natrij kloridom diaco 50 g/1000 ml+ 9 g/1000 ml otopina za infuziju
exicohealthcare d.o.o. - glukoza, natrijumhlorid - otopina za infuziju - 50 g/1000 ml+ 9 g/1000 ml - 1 boca sadrži: 50 g glukoze (u obliku glukoza,monohidrat) i 9 g natrijumhlorida
pemetrexed pfizer (previously pemetrexed hospira)
pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastična sredstva - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.
pemetrexed sandoz
sandoz gmbh - pemetreksed dinatrij hemipentahidrat - carcinoma, non-small-cell lung; mesothelioma - antineoplastična sredstva - maligni mesothelioma плевры Пеметрексед Сандоз u kombinaciji s цисплатином indiciran za liječenje naivne kemoterapije u bolesnika s operirati raka mesothelioma плевры. non-mali rak pluća stanice Пеметрексед Сандоз u kombinaciji s цисплатином indiciran za prva linija terapije u bolesnika s lokalno-uobičajena ili metastatskih немелкоклеточным raka pluća nego drugi uglavnom плоскоклеточной гистологией. Пеметрексед Сандоз prikazan kao monoterapija za liječenje местнораспространенного ili метастатического немелкоклеточного raka pluća, druge, nego pretežno плоскоклеточного гистологии kod pacijenata, bolest kojoj se ne прогрессировало odmah nakon kemoterapije платиносодержащей. Пеметрексед Сандоз prikazan kao monoterapija za drugu liniju liječenja bolesnika s lokalno-uobičajena ili metastatskih немелкоклеточным raka pluća nego drugi uglavnom плоскоклеточной гистологией.